X
20
Life Technologies Corporation Grand Island Us, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Proteose Peptone, No. 4, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-393 - Rev 01
This TSE Type CEP, issued on February 21, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.